TVAX Biomedical
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) (NCT05685004) | TVAX Biomedical | 2023-09-15 |
Track TVAX Biomedical automatically
Every clearance here is in the API, with alerts when new ones post.